期刊文献+

Ⅲ型高脂蛋白血症肾脏损害的临床病理特征——附3例报告并文献复习

Renal disease associated with type Ⅲ hyperlipoproteinemia:a report of three cases with literature review
暂未订购
导出
摘要 目的:探讨Ⅲ型高脂蛋白血症合并肾损害患者的临床病理特征。方法:回顾分析3例(2例女性,1例男性)Ⅲ型高脂蛋白血症合并肾损害患者的临床、实验室指标及病理特点。结果:3例患者均表现为蛋白尿,无镜下血尿,血脂及载脂蛋白E(ApoE)升高,肾小球内可见CD68染色阳性的泡沫细胞,电镜下泡沫细胞胞质内见脂性空泡和(或)致密层状的嗜锇性小体分布。结论:Ⅲ型高脂蛋白血症可引起肾脏损害,病理表现为肾小球系膜区和袢内泡沫细胞聚集。 Objective:To explore clinicopathological features of 3 patients with type Ⅲ hyperlipoproteinemia and renal diseases. Methodology:Three patients with type Ⅲ hyperlipoproteinemia and renal biopsy-proven kidney diseases were retrospectively evaluated. The clinical manifestation and pathological features were analyzed. Results:All three patients(2 females and 1 male) had proteinuria,significantly elevated blood lipids and apolipoprotein E(ApoE),but without microhematuria.Histopathology revealed presence of CD68 positive foam cells in the glomerulus.Electron microscopy showed lipid vacuoles or osmiophilic lamellar bodies in the cytoplasm of foam cells. Conclusion:Renal diseases associated with type Ⅲ hyperlipoproteinemia was characterized by proteinuria,hyperlipidemia,and increased glomerular volume with foam cells infiltration.
作者 钟永忠 朱莹 曾彩虹 ZHONG Yongzhong;ZHU Ying;ZENG Caihong(National Clinical Research Center of Kidney Diseases,Jinling Hospital,Nanjing University School of Medicine,Nanjing 210016,China;Departmgent of Nephrology,Hangzhou Hospital of Traditional Chinese Medicine,Hangzhou 310007,China)
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2019年第5期418-422,434,共6页 Chinese Journal of Nephrology,Dialysis & Transplantation
基金 国家重点研发计划项目(2016YFC0901202)
关键词 Ⅲ型高脂蛋白血症 载脂蛋白E 泡沫细胞 type Ⅲ hyperlipoproteinemia apolipoprotein E foam cells
  • 相关文献

参考文献1

二级参考文献30

  • 1张小瑛,崔若兰,李霖,李闻捷.改良的LCAT测定及其在肾脏疾病中的临床意义[J].肾脏病与透析肾移植杂志,1995,4(4):318-319. 被引量:4
  • 2Kuivenhoven JA, Pritchard H, Hill J, et al.The molecular pathology of lecithin : cholesterol acyhransferase ( LCAT ) deficiency syndromes. J Lipid Res, 1997,38 (2) : 191-205.
  • 3Shoji K, Morita H, Ishigaki Y, et al. Lecithin-cholesterol acyltransferase (LCAT) deficiency without mutations in the coding sequence : a case report and literature review. Clin Nephrol, 2011,76 (4) :323-328.
  • 4Li M, Kuivenhoven JA, Ayyobi AF, et al. T→ G or T→A mutation introduced in the branchpoint consensus sequence of intron 4 of lecithin : cholesterol aeyltransferase ( LCAT ) gene : intron retention causing LCAT deficiency. Biochim Biophys Acta, 1998, 1391 (2) :256-264.
  • 5Frase~t GM,Soverini L, Tampieri E, et al.A 33-year-old man with nephrotie syndrome and lecithin-cholesterol aeyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene. Nephrol Dial Transplant,2004,19(6) : 1622-1624.
  • 6Gjone E, Blomhoff JP, Skarbovik AJ. Possible association between an abnormal low density lipoprotein and nephropathy in lecithin: cholesterol aeyltransferase deficieney.Cliniea Chimica Aeta, 1974,54 (1) :11-8.
  • 7Guefin M, Dachet C, Goulinet S, et al. Familial lecithin : cholesterol aeyltransferase deficiency: molecular analysis of a compound heterozygote : LCAT ( Arg<sup> 147</sup>→Trp) and LCAT ( Tyr< sup> 171 </sup>→Stop).Atberosclerosis, 1997,131 ( 1 ) : 85 -95.
  • 8Takahashi S, Hiromura K, Tsukida M, et al. Nephrotie syndrome caused by immune-mediated acquired LCAT deficiency. J Am Soc Nephrol,2013,24(8) : 1305-1312.
  • 9Simonelli S, Gianazza E, Mombelli G, et al. Severe high-density lipoprotein deficiency associated with autoantibodies against lecithin: cholesterol acyltransferase in non-Hodgkin lymphoma. Arch Intern Med,2012,172(2) : 179-181.
  • 10Vaziri ND, Liang K, Parks JS. Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome.Am J Physiol Renal Physiol, 2001,280( 5 ) : F823-828.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部